Eliminates Ricin Toxicity
Production in non-toxic plants e.g. Camelina or yeast completely removes the risk of ricin contamination and detoxification costs.
Ricinoleic Acid (RA) is a unique hydroxylated fatty acid critical for high-performance Lubricants/Nylon Precursor materials, serving as a base for polyurethanes, surfactants, and specialized plastics. Its conventional supply faces critical issues: Traditionally extracted from castor bean oil (toxic concerns); variable yield. The presence of the potent toxin ricin in the castor plant complicates processing and raises safety concerns.
CD Biosynsis offers two advanced bio-based solutions: Metabolic Engineering: Engineer oilseed plants (e.g., Camelina sativa) to overexpress Ricinus communis Hydroxylase (FAH12) for high accumulation in seeds. This genetic modification allows for RA production in non-toxic, easy-to-harvest oilseeds. Alternatively, we perform Biosynthesis in yeast by introducing the Hydroxy Fatty Acid pathway. This fermentation-based route offers a highly controlled, high-yield, and food-grade safe source of Ricinoleic Acid, entirely bypassing the castor plant toxicity risk.
Get a QuoteThe traditional supply chain for Ricinoleic Acid is constrained by these factors:
A bio-based platform in non-toxic hosts is needed to stabilize supply and purity.
CD Biosynsis provides flexible, non-toxic production platforms for Ricinoleic Acid RA:
Engineering Non-Toxic Oilseed Crops
We engineer safe oilseed plants e.g. Camelina sativa to overexpress the FAH12 hydroxylase for high RA accumulation in seeds.
Yeast Biosynthesis Platform
We introduce the Hydroxy Fatty Acid pathway into yeast hosts e.g. Yarrowia lipolytica or S. cerevisiae to achieve high titer fermentation of RA.
Customized Fatty Acid Profile
We engineer fatty acid synthesis to control chain length and hydroxyl position, allowing production of RA variants for specialized polymers.
Bioprocess Optimization
We optimize fermentation conditions and downstream oil extraction to maximize yield and purity of the bio-based RA.
These engineered platforms provide a non-toxic, scalable, and stable alternative to castor-based RA supply.
Our Ricinoleic Acid RA engineering service offers these core benefits:
Eliminates Ricin Toxicity
Production in non-toxic plants e.g. Camelina or yeast completely removes the risk of ricin contamination and detoxification costs.
Stable and Predictable Yields
Fermentation or controlled oilseed engineering ensures consistent and high yields independent of climate and geographical instability.
Access to Customizable Hydroxy Lipids
The yeast platform allows for genetic manipulation to produce novel hydroxy fatty acids beyond natural castor oil diversity.
Sustainable Feedstock Use
Uses renewable sugars e.g. glucose or non-food biomass in yeast or non-food oilseeds, reducing competition with food supply.
Enhanced Downstream Purity
The engineered process eliminates complex detoxification steps, simplifying downstream processing and achieving higher purity RA for polymer grade.
We provide a sustainable, non-toxic, and high-performance RA production platform.
Our Ricinoleic Acid RA engineering service follows a rigorous multi-stage workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a stable, non-toxic, Ricinoleic Acid RA supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Ricinoleic Acid RA so valuable as a Lubricant/Nylon Precursor?
RA is unique among common fatty acids because of its hydroxyl group at carbon position 12. This functional group makes it suitable for polymerization to produce polyurethanes and high-performance Nylon e.g. Nylon-11 and high-temperature lubricants that cannot be made from unfunctionalized oils.
What is the advantage of using Camelina sativa instead of castor?
Camelina sativa is a non-food oilseed crop that can be grown on marginal lands and does not produce ricin or other toxins. By introducing the FAH12 gene into Camelina, we transfer RA production to a safe, easy-to-process, and sustainable plant host, eliminating the toxicity issues associated with castor beans.
How does yeast biosynthesis compare to plant engineering?
Yeast biosynthesis is a faster and more controlled fermentation process, ideal for producing high-purity and custom RA variants with high titer. Plant engineering offers a high-volume, low-cost solution at the agricultural scale. The choice depends on the required annual volume and the specificity of the fatty acid product e.g. commodity lubricants vs. specialty polymers.
What is the estimated project timeline?
For yeast biosynthesis, the timeline is typically 30-40 weeks for a validated high-titer fermentation protocol. Plant engineering requires longer e.g. 60-80 weeks due to the time needed for stable germination and seed oil analysis.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.